CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 2-(4-ethoxyphenyl)-2-methylpropan-1-ol
Accession: CHEBI:39350
browse the term
Definition: A propan-1-ols that has formula C12H18O2.
Synonyms: related_synonym: 4-ethoxy-beta,beta-dimethylbenzeneethanol; Formula=C12H18O2; InChI=1S/C12H18O2/c1-4-14-11-7-5-10(6-8-11)12(2,3)9-13/h5-8,13H,4,9H2,1-3H3; InChIKey=OZEZBKUHAGFQME-UHFFFAOYSA-N; SMILES=CCOc1ccc(cc1)C(C)(C)CO
xref: Beilstein:5508387; CAS:83493-63-4
G
Akr7a3
aldo-keto reductase family 7 member A3
multiple interactions
EXP
[ethofenprox co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA
CTD
PMID:22467020
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Ar
androgen receptor
multiple interactions
ISO
Dihydrotestosterone inhibits the reaction [ethofenprox results in increased activity of AR protein]
CTD
PMID:15064155
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases activity
EXP
ethofenprox results in increased activity of CYP1A1 protein
CTD
PMID:20009351
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
multiple interactions
EXP
[ethofenprox co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA
CTD
PMID:22467020
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Esr1
estrogen receptor 1
decreases activity
EXP
ethofenprox results in decreased activity of ESR1 protein
CTD
PMID:20410157
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Gsta5
glutathione S-transferase alpha 5
multiple interactions
EXP
[ethofenprox co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA
CTD
PMID:22467020
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[ethofenprox co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA
CTD
PMID:22467020
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
ethofenprox binds to and results in increased activity of NR1I2 protein
CTD
PMID:21115097
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions increases activity
EXP ISO
[ethofenprox co-treated with Diethylnitrosamine] results in decreased expression of NR1I3 mRNA; ethofenprox affects the localization of and results in increased activity of NR1I3 protein ethofenprox results in increased activity of NR1I3 protein
CTD
PMID:22467020 PMID:28927721
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Sult2a1
sulfotransferase family 2A member 1
multiple interactions
EXP
[ethofenprox co-treated with Diethylnitrosamine] results in decreased expression of SULT2A1 mRNA
CTD
PMID:22467020
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions
EXP
[ethofenprox co-treated with Diethylnitrosamine] results in increased expression of UGT1A6 mRNA
CTD
PMID:22467020
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all